If you’ve noticed the signs of male pattern baldness — say, a thinning hairline or a bald patch on the crown of your head — a ...

Sanofi and Regeneron’s Dupixent (dupilumab) has been approved by the US Food and Drug Administration (FDA) to treat bullous ...

Medically reviewed by Katlein Franca, MD Eczema is a chronic (long-lasting) inflammatory condition that causes rashes of scaly, irritated, itchy, dry skin. Affected areas can change color and harden.

The kidneys are responsible for filtering waste from the blood, balancing fluids, and managing minerals like calcium and ...

The FDA approved dupilumab (Dupixent) as the first targeted drug for bullous pemphigoid, a rare blistering skin disease that ...

Ron Reimink knew how uncomfortable and annoying swimmer’s itch could be. He spent much of his adult life trying to eradicate ...

The Food and Drug Administration (FDA) has approved Dupixent ® (dupilumab) for the treatment of adult patients with bullous pemphigoid.

The FDA approved Dupixent for the treatment of adults with bullous pemphigoid, a rare skin disease often uncontrolled with ...

Dupilumab was approved by the FDA to treat bullous pemphigoid, that demonstrated its efficacy in achieving sustained disease ...

The Food and Drug Administration approved the drug for adult patients with bullous pemphigoid, which mainly affects the ...

Discover life-changing eczema treatments and remedies that provide real relief. From prescription breakthroughs to natural ...